The He laboratory applies a variety of genomic, epigenomic experimental and computational approaches to elucidate the functional role of epigenetic regulation in cancer development, progression and drug response, with a special focus on the interplay between epigenetic regulator and noncoding RNA. Combine the experimental and computational expertise, we are in a unique position to make major contributions to both the general understanding of cancer biology and the improvement of epigenetic therapy.
Dr. Housheng Hansen He
11-305 PMCRT
101 College St
Toronto, ON M5G 1L7
Phone: 416 581 7736
Email: hansenhe@uhnresearch.ca
Amelia Navarrete
PMCRT 5-351B and 13-701
101 College St
Toronto, ON M5G 1L7
Phone: 416 581 7559
Email: Amelia.Navarrete@uhnresearch.ca
Sujun and Guanghui's scRNA-seq paper is online with highlight of News&views from Nature Cell Biology. Read it here! And read the paper here.
25/11/2020Sujun and Guanghui’s single-cell RNA-seq study was accepted to Nature Cell Biology. Congratulations!
24/11/2020Fraser and Musa’s work on CRISPR screen in double negative T cells was accepted to Blood. This was a great collaboration with Dr. Li Zhang’s group.
24/11/2020Musa and Fraser’s CRISPRi screen paper was accepted to Nature Communications, congratulations!
23/11/2020Dr. Xinpei Ci joined our lab as a research associate. Welcome on board, Xinpei!
25/09/2020Congratulations to Sujun for winning a Princess Margaret postdoctoral fellowship!
31/08/2020Sujun's co-first author paper on LSD1 and FOXA1 is published!
18/08/2020Mona’s review paper on FOXA1 has been accepted to Protein & Cell, congratulations Mona!
03/08/2020Musa has accepted a scientist position at Roche, congratulations Musa!